Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines
暂无分享,去创建一个
S. Fox | K. Dutton-Regester | N. Hayward | J. Christensen | R. Pearson | H. Do | A. Dobrovic | G. McArthur | C. Cullinane | Kelly Waldeck | K. Sheppard | C. Mitchell | Laura Kirby | S. Randolph | Donald P. Cameron | Wendy Liu | Nicholas Jene | J. Foo | Claire A. Martin | R. J. Young | C. Mitchell